The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human fetal-placental circulation

Leslie Myatt, Anthony S. Brewer, Diane E. Brockman

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

OBJECTIVE: This study compared the effects of big endothelin-1, endothelin-1, and endothelin-3 and whether endothelin-converting enzyme was present in the human fetal-placental circulation. STUDY DESIGN: Single cotyledons of term placentas were dually perfused in vitro, and increases in fetal-placental perfusion pressure to bolus injections of big endothelin-1, endothelin-1, and endothelin-3 (8 × 10-10 to 1 × 10-7 mol/L) were recorded. Responses to big endothelin-1 (10-7 Mol/L) were measured in the same placenta before and after perfusion of the fetal-placental circulation with the neutral metalloprotease inhibitor phosphoramidon (10-5 mol/L), which acts as an endothelin-converting enzyme inhibitor. All experiments were performed in at least five separate placentas. RESULTS: Significant concentration-dependent increases in fetal-placental perfusion pressure were seen with endothelin-1 (p <0.0005), endothelin-3 (p <0.0256), and big endothelin-1 (p <0.0034, analysis of variance). Big endothelin-1 always elicited transient vasodilatation before constriction. Phosphoramidon significantly inhibited the vasoconstrictor effect of big endothelin-1 (p <0.039, paired t test). CONCLUSION: The three endothelins tested are vasoconstrictors, and endothelin-converting enzyme is present in the fetal-placental circulation.

Original languageEnglish (US)
Pages (from-to)1651-1656
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume167
Issue number6
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Placental Circulation
Endothelin-3
Endothelin-1
Placenta
Perfusion
Vasoconstrictor Agents
Pressure
Cotyledon
Endothelins
Metalloproteases
Enzyme Inhibitors
Constriction
Vasodilation
Analysis of Variance

Keywords

  • Endothelin
  • fetus
  • placenta
  • vasoconstriction

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human fetal-placental circulation. / Myatt, Leslie; Brewer, Anthony S.; Brockman, Diane E.

In: American Journal of Obstetrics and Gynecology, Vol. 167, No. 6, 1992, p. 1651-1656.

Research output: Contribution to journalArticle

@article{5fe0cc1db9e1494e8e86c391001b6a64,
title = "The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human fetal-placental circulation",
abstract = "OBJECTIVE: This study compared the effects of big endothelin-1, endothelin-1, and endothelin-3 and whether endothelin-converting enzyme was present in the human fetal-placental circulation. STUDY DESIGN: Single cotyledons of term placentas were dually perfused in vitro, and increases in fetal-placental perfusion pressure to bolus injections of big endothelin-1, endothelin-1, and endothelin-3 (8 × 10-10 to 1 × 10-7 mol/L) were recorded. Responses to big endothelin-1 (10-7 Mol/L) were measured in the same placenta before and after perfusion of the fetal-placental circulation with the neutral metalloprotease inhibitor phosphoramidon (10-5 mol/L), which acts as an endothelin-converting enzyme inhibitor. All experiments were performed in at least five separate placentas. RESULTS: Significant concentration-dependent increases in fetal-placental perfusion pressure were seen with endothelin-1 (p <0.0005), endothelin-3 (p <0.0256), and big endothelin-1 (p <0.0034, analysis of variance). Big endothelin-1 always elicited transient vasodilatation before constriction. Phosphoramidon significantly inhibited the vasoconstrictor effect of big endothelin-1 (p <0.039, paired t test). CONCLUSION: The three endothelins tested are vasoconstrictors, and endothelin-converting enzyme is present in the fetal-placental circulation.",
keywords = "Endothelin, fetus, placenta, vasoconstriction",
author = "Leslie Myatt and Brewer, {Anthony S.} and Brockman, {Diane E.}",
year = "1992",
doi = "10.1016/0002-9378(92)91756-Z",
language = "English (US)",
volume = "167",
pages = "1651--1656",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human fetal-placental circulation

AU - Myatt, Leslie

AU - Brewer, Anthony S.

AU - Brockman, Diane E.

PY - 1992

Y1 - 1992

N2 - OBJECTIVE: This study compared the effects of big endothelin-1, endothelin-1, and endothelin-3 and whether endothelin-converting enzyme was present in the human fetal-placental circulation. STUDY DESIGN: Single cotyledons of term placentas were dually perfused in vitro, and increases in fetal-placental perfusion pressure to bolus injections of big endothelin-1, endothelin-1, and endothelin-3 (8 × 10-10 to 1 × 10-7 mol/L) were recorded. Responses to big endothelin-1 (10-7 Mol/L) were measured in the same placenta before and after perfusion of the fetal-placental circulation with the neutral metalloprotease inhibitor phosphoramidon (10-5 mol/L), which acts as an endothelin-converting enzyme inhibitor. All experiments were performed in at least five separate placentas. RESULTS: Significant concentration-dependent increases in fetal-placental perfusion pressure were seen with endothelin-1 (p <0.0005), endothelin-3 (p <0.0256), and big endothelin-1 (p <0.0034, analysis of variance). Big endothelin-1 always elicited transient vasodilatation before constriction. Phosphoramidon significantly inhibited the vasoconstrictor effect of big endothelin-1 (p <0.039, paired t test). CONCLUSION: The three endothelins tested are vasoconstrictors, and endothelin-converting enzyme is present in the fetal-placental circulation.

AB - OBJECTIVE: This study compared the effects of big endothelin-1, endothelin-1, and endothelin-3 and whether endothelin-converting enzyme was present in the human fetal-placental circulation. STUDY DESIGN: Single cotyledons of term placentas were dually perfused in vitro, and increases in fetal-placental perfusion pressure to bolus injections of big endothelin-1, endothelin-1, and endothelin-3 (8 × 10-10 to 1 × 10-7 mol/L) were recorded. Responses to big endothelin-1 (10-7 Mol/L) were measured in the same placenta before and after perfusion of the fetal-placental circulation with the neutral metalloprotease inhibitor phosphoramidon (10-5 mol/L), which acts as an endothelin-converting enzyme inhibitor. All experiments were performed in at least five separate placentas. RESULTS: Significant concentration-dependent increases in fetal-placental perfusion pressure were seen with endothelin-1 (p <0.0005), endothelin-3 (p <0.0256), and big endothelin-1 (p <0.0034, analysis of variance). Big endothelin-1 always elicited transient vasodilatation before constriction. Phosphoramidon significantly inhibited the vasoconstrictor effect of big endothelin-1 (p <0.039, paired t test). CONCLUSION: The three endothelins tested are vasoconstrictors, and endothelin-converting enzyme is present in the fetal-placental circulation.

KW - Endothelin

KW - fetus

KW - placenta

KW - vasoconstriction

UR - http://www.scopus.com/inward/record.url?scp=0026676640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026676640&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(92)91756-Z

DO - 10.1016/0002-9378(92)91756-Z

M3 - Article

C2 - 1471681

AN - SCOPUS:0026676640

VL - 167

SP - 1651

EP - 1656

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -